95 related articles for article (PubMed ID: 1509751)
1. Results of the multicenter evaluation of the CEDIA Theophylline assay.
Klein G; Castiñeiras MJ; Collinsworth W; Courbe A; Delavenne M; Hänseler E; Hannak D; Kaspar P; Kattermann R; Knoke A
Wien Klin Wochenschr Suppl; 1992; 191():31-7. PubMed ID: 1509751
[TBL] [Abstract][Full Text] [Related]
2. Results of the multicenter evaluation of the CEDIA Phenytoin assay.
Klein G; Collinsworth W; Courbe A; Fuentes-Arderiu X; Graham J; Hänseler E; Hannak D; Kattermann R; Knoke A; Lehmann P
Wien Klin Wochenschr Suppl; 1992; 191():38-42. PubMed ID: 1509752
[TBL] [Abstract][Full Text] [Related]
3. Results of the multicenter evaluation of the CEDIA Phenobarbital assay.
Klein G; Collinsworth W; Courbe A; Diez O; Domke I; Hänseler E; Haux P; Kattermann R; Knoke A; Lehmann P
Wien Klin Wochenschr Suppl; 1992; 191():43-7. PubMed ID: 1509753
[TBL] [Abstract][Full Text] [Related]
4. Analyses of the pattern of therapeutic drug monitoring in a university hospital laboratory. Suitability and performance of the CEDIA assays.
Hänseler E; Bigler S; Wad N
Wien Klin Wochenschr Suppl; 1992; 191():23-6. PubMed ID: 1509748
[TBL] [Abstract][Full Text] [Related]
5. Results of the multicenter evaluation of a novel homogeneous immunoassay for digoxin based on the cloned enzyme donor immunoassay technology.
Jarausch J; Collinsworth W; Cano Y; Hafner G; Hammer E; Malandain H; Pokieser L; Redondo FL; Schlebusch H; Taylor A
Wien Klin Wochenschr Suppl; 1992; 191():69-73. PubMed ID: 1509759
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatographic analysis of phenobarbital, phenytoin, and theophylline.
Hannak D; Haux P; Scharbert F; Kattermann R
Wien Klin Wochenschr Suppl; 1992; 191():27-31. PubMed ID: 1509749
[TBL] [Abstract][Full Text] [Related]
7. Results of the multicenter evaluation of the CEDIA cortisol assay.
Horn K; Haux P; Kattermann R; Oellerich M; Knoke A; Sommer R; Weissmann A; Vockenhuber M; Clark D; Ng RH
Wien Klin Wochenschr Suppl; 1992; 191():80-5. PubMed ID: 1509762
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the CEDIA digoxin assay on Boehringer Mannheim/Hitachi 717 analyzer.
Redondo FL
Wien Klin Wochenschr Suppl; 1992; 191():66-8. PubMed ID: 1509758
[TBL] [Abstract][Full Text] [Related]
9. CEDIA--homogeneous immunoassays for the 1990s and beyond.
Coty WA; Loor R; Bellet N; Khanna PL; Kaspar P; Baier M
Wien Klin Wochenschr Suppl; 1992; 191():5-11. PubMed ID: 1509755
[TBL] [Abstract][Full Text] [Related]
10. Results of the multicenter evaluation of a homogeneous immunoassay for digitoxin based on the cloned enzyme donor immunoassay technology.
Jarausch J; Cano Y; Hammer E; Hafner G; Kaspar P; Malandain H; Pokieser L; Wieland H; Willems D; Windisch M
Wien Klin Wochenschr Suppl; 1992; 191():73-6. PubMed ID: 1509760
[TBL] [Abstract][Full Text] [Related]
11. Economic aspects of therapeutic drug monitoring.
Feuerstein J; Thomae R
Wien Klin Wochenschr Suppl; 1992; 191():85-7. PubMed ID: 1509763
[TBL] [Abstract][Full Text] [Related]
12. The determination of thyroxine and thyroxine uptake with new homogeneous enzyme immunoassays using Boehringer Mannheim/Hitachi analysis systems.
Horn K; Castiñeiras MJ; Ortolá J; Kock R; Perriard FC; Bittner S; Pairet JV; Ers P; Boulanger J; Zeidner S
Eur J Clin Chem Clin Biochem; 1991 Oct; 29(10):697-703. PubMed ID: 1764546
[TBL] [Abstract][Full Text] [Related]
13. Multicentre evaluation of the Boehringer Mannheim/Hitachi 747 analysis system.
Bonini P; Ceriotti F; Keller F; Brauer P; Stolz H; Pascual C; García Beltrán L; Vonderschmitt DJ; Pei P
Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):881-99. PubMed ID: 1489865
[TBL] [Abstract][Full Text] [Related]
14. Interlaboratory variability in drug assay: a comparison of quality control data with reanalysis of routine patient samples. I: Anticonvulsant drugs and theophylline. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry.
Ther Drug Monit; 1991 Mar; 13(2):131-9. PubMed ID: 2053120
[TBL] [Abstract][Full Text] [Related]
15. Interlaboratory variability in drug assay: a comparison of quality control data with reanalysis of routine patient samples. II: Digoxin. Clinical Pharmacology and Toxicology Study Group, Italian Society for Clinical Biochemistry.
Ther Drug Monit; 1991 Mar; 13(2):140-5. PubMed ID: 2053121
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring for the 1990s: meeting the laboratory needs of a changing environment.
Wu AH
Wien Klin Wochenschr Suppl; 1992; 191():19-22. PubMed ID: 1509747
[TBL] [Abstract][Full Text] [Related]
17. Methods of theophylline assay and therapeutic monitoring of this drug.
Mounié J; Richard L; Ribon B; Hersant J; Sarmini H; Houin G
Ann Biol Clin (Paris); 1990; 48(5):287-93. PubMed ID: 2195925
[TBL] [Abstract][Full Text] [Related]
18. [Results of the multicenter evaluation of a new test for measuring beta-N-acetylglucosaminidase in urine].
Klein G
Wien Klin Wochenschr Suppl; 1991; 189():31-8. PubMed ID: 1962480
[TBL] [Abstract][Full Text] [Related]
19. CEDIA mycophenolic acid assay compared with HPLC-UV in specimens from transplant recipients.
Westley IS; Ray JE; Morris RG
Ther Drug Monit; 2006 Oct; 28(5):632-6. PubMed ID: 17038877
[TBL] [Abstract][Full Text] [Related]
20. [Serum creatinine assay: results of a multicentric study with 16 analytical systems].
Vassault A; Cherruau B; Labbe D; Alabrune B; Baltassat P; Bonete R; Carroger G; Costantini S; Georges P; Giroud C
Ann Biol Clin (Paris); 1992; 50(2):81-95. PubMed ID: 1443797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
